英文摘要 |
Although there are varieties of diseases belonging to inborn error of metabolism (IEM), patient number is relatively small compared to other common disease. Because of the smaller patient number, the development of treatment for IEM is relatively slow. The traditional treatment for IEM patients includes diet control, toxin removal, supplementation, or small molecule therapy. Recently, the management of IEM entered a new era because of the development of gene therapy. Currently, treatment of IEM using lentivirus, antisense oligonucleotide, and RNAi had been approved. Also, products for adeno-associated virus and mRNA therapy using lipid nanoparticle are emerging clinical trials. We believe there will be more and more treatment available soon. |